Cargando…

Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties

Novel series of amidines were synthesized via the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1H)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analys...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sheref, Essmat M., Tawfeek, Hendawy N., Hassan, Alaa A., Bräse, S., Elbastawesy, Mohammed A. I., Gomaa, Hesham A. M., Mostafa, Yaser A., Youssif, Bahaa G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716094/
https://www.ncbi.nlm.nih.gov/pubmed/36465858
http://dx.doi.org/10.3389/fchem.2022.1039176
_version_ 1784842606077804544
author El-Sheref, Essmat M.
Tawfeek, Hendawy N.
Hassan, Alaa A.
Bräse, S.
Elbastawesy, Mohammed A. I.
Gomaa, Hesham A. M.
Mostafa, Yaser A.
Youssif, Bahaa G. M.
author_facet El-Sheref, Essmat M.
Tawfeek, Hendawy N.
Hassan, Alaa A.
Bräse, S.
Elbastawesy, Mohammed A. I.
Gomaa, Hesham A. M.
Mostafa, Yaser A.
Youssif, Bahaa G. M.
author_sort El-Sheref, Essmat M.
collection PubMed
description Novel series of amidines were synthesized via the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1H)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analysis. The reaction conditions were optimized using cyclohexanone (2), piperidine (3a), and 4-azido-quinolin-2(1H)-one (1a) under an air atmosphere. The new compounds 4a-l and 5a-c were tested for antiproliferative activity against four cancer cell lines using doxorubicin as a reference drug. The most potent derivatives were compounds 4b, 4d, 4e, 4i, and 5c, with GI(50) ranging from 1.00 µM to 1.50 µM. Compound 5c was the most effective derivative against the four cancer cell lines, outperforming doxorubicin. The compounds 4b, 4d, 4e, 4i, and 5c were studied further as topoisomerase I and IIα inhibitors. The compounds tested showed selective inhibition of topo I over topo IIα. Finally, docking studies explain why these compounds prefer topo I over topo IIα.
format Online
Article
Text
id pubmed-9716094
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97160942022-12-03 Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties El-Sheref, Essmat M. Tawfeek, Hendawy N. Hassan, Alaa A. Bräse, S. Elbastawesy, Mohammed A. I. Gomaa, Hesham A. M. Mostafa, Yaser A. Youssif, Bahaa G. M. Front Chem Chemistry Novel series of amidines were synthesized via the interaction between alicyclic amines, cyclic ketones, and a highly electrophilic 4-azidoquinolin-2(1H)-ones without any catalyst or additive. All the obtained products were elucidated based on NMR spectroscopy, mass spectrometry, and elemental analysis. The reaction conditions were optimized using cyclohexanone (2), piperidine (3a), and 4-azido-quinolin-2(1H)-one (1a) under an air atmosphere. The new compounds 4a-l and 5a-c were tested for antiproliferative activity against four cancer cell lines using doxorubicin as a reference drug. The most potent derivatives were compounds 4b, 4d, 4e, 4i, and 5c, with GI(50) ranging from 1.00 µM to 1.50 µM. Compound 5c was the most effective derivative against the four cancer cell lines, outperforming doxorubicin. The compounds 4b, 4d, 4e, 4i, and 5c were studied further as topoisomerase I and IIα inhibitors. The compounds tested showed selective inhibition of topo I over topo IIα. Finally, docking studies explain why these compounds prefer topo I over topo IIα. Frontiers Media S.A. 2022-11-18 /pmc/articles/PMC9716094/ /pubmed/36465858 http://dx.doi.org/10.3389/fchem.2022.1039176 Text en Copyright © 2022 El-Sheref, Tawfeek, Hassan, Bräse, Elbastawesy, Gomaa, Mostafa and Youssif. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
El-Sheref, Essmat M.
Tawfeek, Hendawy N.
Hassan, Alaa A.
Bräse, S.
Elbastawesy, Mohammed A. I.
Gomaa, Hesham A. M.
Mostafa, Yaser A.
Youssif, Bahaa G. M.
Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
title Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
title_full Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
title_fullStr Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
title_full_unstemmed Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
title_short Synthesis of novel amidines via one-pot three component reactions: Selective topoisomerase I inhibitors with antiproliferative properties
title_sort synthesis of novel amidines via one-pot three component reactions: selective topoisomerase i inhibitors with antiproliferative properties
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716094/
https://www.ncbi.nlm.nih.gov/pubmed/36465858
http://dx.doi.org/10.3389/fchem.2022.1039176
work_keys_str_mv AT elsherefessmatm synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT tawfeekhendawyn synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT hassanalaaa synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT brases synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT elbastawesymohammedai synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT gomaaheshamam synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT mostafayasera synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties
AT youssifbahaagm synthesisofnovelamidinesviaonepotthreecomponentreactionsselectivetopoisomeraseiinhibitorswithantiproliferativeproperties